Patient-Friendly Studies: Gaining Effective Input Along the Drug-Development Continuum
One of a series of live panels recorded at the WCG Patient Advocacy Forums in Washington D.C. in October, 2019.
How do we make clinical studies more patient-centric? What does “patient-centric” even mean?
Steven Taylor, president and CEO of the Sjogren’s Foundation and Ellen Wagner of Parent Project Muscular Dystrophy (PPMD)—and the parent of a son with Duchenne Muscular Dystrophy (DMD)—shared their insights into how patients and advocates can amplify their voices and provide meaningful input into clinical trials. Danya Kaye, director of business development, R&D and innovation at Inspire, led the conversation.
Click the slides above, or download the PDF to read insights on this topic from patients, patient advocates, and industry leaders.